(NEO) stock saw a modest uptick, ending the day at $14.71 which represents a slight increase of $0.93 or 6.75% from the prior close of $13.78. The stock opened at $14.95 and touched a low of $14.48 ...
Check the time stamp on this data. Updated AI-Generated Signals for Neogenomics Inc. (NEO) available here: NEO. Type a few ...
On Monday, NeoGenomics, Inc. (NEO) stock saw a decline, ending the day at $12.63 which represents a decrease of $-2.14 or -14.49% from the prior close of $14.77. The stock opened at $14.11 and touched ...
NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. FT.
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
Benchmark Co. analyst Bruce Jackson maintained a Hold rating on NeoGenomics (NEO – Research Report) today. The company’s shares closed ...
The put/call ratio of NEO is 0.21, indicating a bullish outlook ... Additionally, our exclusive stock picks are powered by ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
In the last twelve months Neo Performance Materials insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the ...
NeoGenomics (NEO – Research Report) received a Hold rating and price target from Benchmark Co. analyst Bruce Jackson today. The company’s ...